Gleostine (NextSource Biotechnology, LLC)


Welcome to the PulseAid listing for the Gleostine drug offered from NextSource Biotechnology, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: NextSource Biotechnology, LLC
NON-PROPRIETARY NAME: lomustine
SUBSTANCE NAME: LOMUSTINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-08-18
END MARKETING DATE: 0000-00-00


Gleostine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGleostine from NextSource Biotechnology, LLC
LABELER NAME: NextSource Biotechnology, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2014-08-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58181-3040_43669261-fce0-45c0-a28a-4871c7d670d5
PRODUCT NDC: 58181-3040
APPLICATION NUMBER: NDA017588

Other LOMUSTINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NextSource Biotechnology, LLCGleostine